RISK MEASURES (3-Year)As of 3/31/2013
  PORTFOLIO BENCHMARK
STANDARD DEVIATION 15.88% 15.01%
ALPHA -1.74% 0.00%
BETA 1.02 1.00
EXCESS RETURN -1.80% 0.00%
R-SQUARED 93.02% 100.00%
TRACKING ERROR 4.21% 0.00%
INFORMATION RATIO -0.43 0.00
SHARPE RATIO 0.68 0.84
MARKET CAPITALIZATIONAs of 3/31/2013 ($ Millions)
  PORTFOLIO BENCHMARK
Weighted Average 79,875.1 100,079.3
Median 31,338.2 13,294.1
Weighted Median 42,565.1 56,469.6
TOP HOLDINGSAs of 3/31/2013
Holding % of Net Assets
CVS CAREMARK CORP 4.18%
QUALCOMM INC 3.85%
GOOGLE INC CL A 3.67%
APPLE INC 3.57%
ECOLAB INC 3.51%
MICROSOFT CORP 3.40%
CAMERON INTERNATIONAL CORP 3.38%
GILEAD SCIENCES INC 3.29%
ALLERGAN INC 3.28%
AMERICAN EXPRESS CO 3.26%
Total 35.40%
ASSET ALLOCATION% of assets as of 3/31/2013
  Equity Fixed Income Cash
Calvert Equity Portfolio 97.31% 0.59% 2.10%
VALUATIONKey Portfolio Statistics as of 3/31/2013
  1 YEAR P/E 3 YEAR EPS GROWTH RETURN ON
EQUITY
PRICE TO
CASH FLOW
PRICE TO
BOOK
Dividend
Yield
PROJECTED TRAILING PROJECTED TRAILING
Calvert Equity Portfolio 16.1 19.0 14.1% 18.5% 20.7% 13.0 3.1 1.1
S&P 500 Index 14.2 15.9 10.4% 27.9% 18.8% 10.1 2.3 2.1
PERFORMANCE Average Annual Returns (%) for Period Ended 3/31/2013
  QTR YTD 1 YEAR 3 YEARS 5 YEARS 10 YEARS SINCE
INCEPTION
INCEPTION
DATE
A Shares (NAV) 8.79 8.79 8.77 10.88 6.25 7.86 7.64 8/24/1987
S&P 500 Index 10.61 10.61 13.96 12.67 5.81 8.53 n/a  
Lipper Large-Cap Growth Funds Index 8.17 8.17 7.04 10.36 5.09 7.40 7.22  
PERFORMANCE ATTRIBUTIONRelative to the S&P 500 Index for the quarter ending 3/31/2013
Performance Attribution Chart
TOP CONTRIBUTORS BY SECTORQuarter ended 3/31/2013
Sector Average Weight Return Contribution
Health Care 14.53% 17.53% 2.42%
Financials 12.13% 14.15% 1.66%
Consumer Staples 11.30% 12.52% 1.39%
Information Technology 27.30% 4.48% 1.29%
Consumer Discretionary 11.46% 8.46% 1.00%
TOP CONTRIBUTORS BY HOLDINGQuarter ended 3/31/2013
Holding Average Weight Return Contribution
Allergan Inc. 4.03% 21.75% 0.97%
Gilead Sciences Inc. 3.03% 33.23% 0.91%
IntercontinentalExchange Inc. 2.28% 31.71% 0.64%
CVS Caremark Corp. 4.28% 14.22% 0.59%
American Express Co. 3.26% 17.76% 0.55%
BOTTOM CONTRIBUTORS BY SECTORQuarter ended 3/31/2013
Sector Average Weight Return Contribution
Telecomm Services 0.00% 0.00% 0.00%
Utilities 0.00% 0.00% 0.00%
Materials 3.58% 11.85% 0.42%
Energy 9.84% 5.24% 0.52%
Industrials 9.85% 9.12% 0.90%
BOTTOM CONTRIBUTORS BY HOLDINGQuarter ended 3/31/2013
Holding Average Weight Return Contribution
Apple Inc. 4.10% -16.49% -0.82%
Suncor Energy Inc. 2.79% -8.63% -0.25%
Edwards Lifesciences Corp. 1.41% -8.88% -0.14%
C.H. Robinson Worldwide Inc. 1.39% -5.37% -0.09%
Juniper Networks Inc. 1.18% -5.74% -0.05%
10 BEST PERFORMERS FOR THE QUARTER as of 3/31/2013
Rank Company Industry Return
1 Gilead Sciences Inc. Health Care 33.23%
2 IntercontinentalExchange Inc. Financials 31.71%
3 B/E Aerospace Inc. Industrials 22.04%
4 Cerner Corp. Health Care 22.04%
5 Allergan Inc. Health Care 21.75%
6 American Express Co. Financials 17.76%
7 PepsiCo Inc. Consumer Staples 16.43%
8 Novartis AG ADS Health Care 16.01%
9 T. Rowe Price Group Inc. Financials 15.54%
10 Cameron International Corp. Energy 15.48%
10 WORST PERFORMERS FOR THE QUARTER as of 3/31/2013
Rank Company Industry Return
1 Apple Inc. Information Technology -16.49%
2 Expeditors International of Washington Inc. Industrials -9.48%
3 Edwards Lifesciences Corp. Health Care -8.88%
4 Suncor Energy Inc. Energy -8.63%
5 Juniper Networks Inc. Information Technology -5.74%
6 C.H. Robinson Worldwide Inc. Industrials -5.37%
7 Kohl's Corp. Consumer Discretionary -2.35%
8 AFLAC Inc. Financials -1.37%
9 AON Plc Financials -0.52%
10 DaVita HealthCare Partners Inc. Health Care 0.33%

Investment in mutual funds involves risk, including possible loss of principal invested. You could lose money on your investment in the Fund or the Fund could underperform because of the following risks: the market prices of stocks held by the Fund may fall; individual investments of the Fund may not perform as expected; and/or the Fund’s portfolio management practices may not achieve the desired result. In addition, large-cap companies may be unable to respond quickly to new competitive challenges, such as changes in technology, and also may not be able to attain the high growth rate of successful smaller companies, especially during periods of economic expansion.

G200ATT FOR INSTITUTIONAL INVESTOR AND BROKER/DEALER USE ONLY. NOT FOR PUBLIC DISTRIBUTION.